Lupin Limited

Lupin Launches Divalproex Sodium ER Tablets USP

Mumbai, September 23, 2020: Pharma major Lupin Limited (Lupin) announced the launch of Divalproex Sodium Extended-Release (ER) Tablets USP, 250 mg…

4 years ago

Lupin Launches Zileuton Extended-Release Tablets

Mumbai, August 11, 2020: Pharma major Lupin Limited (Lupin) announced the launch of Zileuton Extended-Release Tablets, 600 mg, having received…

4 years ago

Lupin and Mylan Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept

Mumbai, June 04, 2020: Lupin Limited (Lupin) and Mylan N.V. (NASDAQ: MYL) today announced that the European Commission (EC) has…

4 years ago

Lupin Receives Approval for Meloxicam Capsules

Mumbai, June 02, 2020: Pharma major Lupin Limited (Lupin) announced that it has received approval for its Meloxicam Capsules, 5 mg…

4 years ago

Lupin in alliance with Natco receives FDA approval for Bosentan Tablets

Mumbai, May 01, 2019: Lupin Limited (Lupin) in alliance with Natco Pharma (Natco) announced that it has received approval for Bosentan…

6 years ago

More than 9,500 visitors: analytica Anacon India, India Lab Expo 2018 and PHARMA Pro&Pack Expo smashes all the records

9,641trade visitors attended 261exhibitors from India and overseas at the trade fair trio Smart Lab Summit, Anacon India Conference and…

6 years ago